Disease-specific survival and locoregional control in tonsillar carcinoma
Autor: | MakKregar, S, Hilgers, FJM, Levendag, PC, Manni, JJ, Hart, AAM, Visser, O, Knegt, PPM, Marres, HAM, TenBroek, FW, Burlage, FR, VanderBeek, JMH, DeJong, RJB |
---|---|
Přispěvatelé: | Faculteit Medische Wetenschappen/UMCG |
Jazyk: | angličtina |
Rok vydání: | 1996 |
Předmět: | |
Zdroj: | Clinical Otolaryngology, 21(6), 550-556. Wiley |
ISSN: | 1986-1990 0307-7772 |
Popis: | In a nationwide survey on oropharyngeal carcinoma in the Netherlands (1986-1990), 380 patients with a tonsillar carcinoma were retrospectively studied. The records of 268 (71%) men and 112 (29%) women with a median age of 59 yr (range 31-91), who had squamous cell carcinoma (272 patients, 98%) or undifferentiated carcinoma (8 patients, 2%) were reviewed with respect to treatment, disease-specific survival and locoregional control. Distribution by stage according to the UICC'92 system was: 27 patients (7%) stage I, 59 (15%) stage II, 99 (26%) stage III, 182 (48%) stage IV and 13 patients (3%) unknown stage. Using a previously reported revised staging system the following distribution was obtained: 118 patients (31%) stage I, 120 (31%) stage II, 67 (18%) stage III, 54 (14%) stage IV and 21 patients (6%) with an unknown stage. Treatment consisted of radiotherapy alone in 231 patients (61%), surgery and radiotherapy in 101 (27%), surgery alone in 30 (8%), chemotherapy in 5 (2%) and 13 patients (3%) did not receive any treatment. At 5-yr the overall survival was 32%, the disease-specific survival 42% and the locoregional control 61%. In patients treated with radiotherapy alone the disease-specific survival was 39%, for surgery and radiotherapy 53% and for surgery alone 83%. The disease-specific survival according to UICC'92 stage was 71% in stage I, 59% in II, 50% in III and 32% in stage IV (P |
Databáze: | OpenAIRE |
Externí odkaz: |